Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?

12 Mar 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Gestational Trophoblastic Disease Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20226525
DOI: 10.1016/j.leukres.2010.02.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?PMID 20226525Read ↗

The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failureSemantic proximity Read ↗

Limited utility of fluorescence<i>in situ</i>hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasmsSemantic proximity Read ↗

FISH analysis in addition to G-band karyotyping: Utility in evaluation of myelodysplastic syndromes?Semantic proximity Read ↗

Diagnostic microRNAs in myelodysplastic syndromeSemantic proximity Read ↗

Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patientsSemantic proximity Read ↗

Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotypeSemantic proximity Read ↗

Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromesSemantic proximity Read ↗

Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-Semantic proximity Read ↗

Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicineSemantic proximity Read ↗

Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhoodSemantic proximity Read ↗

Fluorescence In Situ Hybridization Testing for −5/5q, −7/7q, +8, and del(20q) in Primary Myelodysplastic Syndrome Correlates With Conventional Cytogenetics in the Setting of an Adequate StudySemantic proximity Read ↗

Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.